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TributyltinTributyltin (TBT), is a man-made pollutants, known to accumulate along the food chain, acting as an endocrine
disruptor in marine organisms, with toxic and adverse effects in many tissues including vascular system. Based
on the absence of speciﬁc studies of TBT effects on endothelial cells, we aimed to evaluate the toxicity of TBT
on primary culture of porcine aortic endothelial cells (pAECs), pig being an excellent model to study human car-
diovascular disease. pAECs were exposed for 24 h to TBT (100, 250, 500, 750 and 1000 nM) showing a dose de-
pendent decrease in cell viability through both apoptosis and necrosis. Moreover the ability of TBT (100 and
500 nM) to inﬂuence endothelial gene expressionwas investigated at 1, 7 and 15h of treatment. Gene expression
of tight junction molecules, occludin (OCLN) and tight junction protein-1 (ZO-1) was reduced while monocyte
adhesion and adhesion molecules ICAM-1 and VCAM-1 (intercellular adhesion molecule-1 and vascular cell ad-
hesion molecule-1) levels increased signiﬁcantly at 1 h. IL-6 and estrogen receptors 1 and 2 (ESR-1 and ESR-2)
mRNAs, after a transient decrease, reached themaximum levels after 15 h of exposure. Finally, we demonstrated
that TBT altered endothelial functionality greatly increasingmonocyte adhesion. These ﬁndings indicate that TBT
deeply alters endothelial proﬁle, disrupting their structure and interferingwith their ability to interact withmol-
ecules and other cells.
© 2015 Elsevier Inc. All rights reserved.1. Introduction
Among man-made pollutants, known to accumulate along the food
chain, organotins, and mainly trisubstituted tin compounds, are espe-
cially dangerous, due to their wide industrial exploitation as polyvinyl
chloride stabilizers, catalysts, pesticides and biocides in antifouling
paints.
Tributyltin (TBT) interact by both covalent and non-covalent bonds
with biomolecules and membrane structures and are considered
among the most toxic substances ever deliberately introduced into en-
vironment (Pagliarani et al., 2013).
In spite of bans of TBT use (IMO 2001), the residue inmarine environ-
ment is still an important concern (Horiguchi, 2012) due to its environ-
mental persistence (Hoch, 2001; Fent, 2004). The contamination of
aquatic environments is especially harmful. Bioaccumulation in tissueslls; (TBT), tributyltin; (OCLN),
rcellular adhesion molecule-1;
leukin-6; (ESR-1 and ESR-2), es-
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ica.forni@unibo.it (M. Forni).of exposed species (Frouin et al., 2010) leads to contamination of seafoods
(Ma et al., 2011) and in turn, mainly through the food chain, of terrestrial
species including human (Kannan et al., 1999; Takahashi et al., 1999).
TBT exerts a toxic effect acting as a classical endocrine disruptor for
marine organisms causing imposex in gastropod mollusks (Gallo and
Tosti, 2013). TBT shows also toxic and adverse effects in many kinds of
cells and tissues of a variety of species, including mammalian (Ohshima
et al., 2005) inwhich affects endocrine system throughdifferent pathway.
Organotins are potent inhibitors of 11β-hydroxysteroid dehydrogenase
type-2 (11β-HSD2) (Atanasov et al., 2005) and shows proadipogenic ac-
tivity in some cell lineages like human and mouse multipotent stromal
stem cells (Kirchner et al., 2010; Li et al., 2011; Penza et al., 2011).
Different cell types have depicted dissimilar levels of tolerance to
TBT, resulting in a diversity of effects and in speciﬁc toxic concentrations
for every cell lineage. In a cultured human granulosa-like tumor cell line,
Saitoh et al. (2001) found a toxic TBT concentration of 1000 ng/mL,
causing cell death within 24 h, while 200 ng/mL induced apoptosis of
the cells. In neurons continuously exposed to TBT for 3 days, Yamada
et al. (2010) observed a TBT-induced death at 30 nM in 4–6 days of cul-
ture and at 50nM in 14–16days of culture,whichmeans that older neu-
rons are more resistant to TBT toxicity. Signiﬁcant loss of viability was
observed in neuroblastoma cells incubated for 24 h with doses of TBT
ranging from 250 nM onward, with a linearity found between 250 nM
and 2 μM (Ferreira et al., 2013) and in a Sertoli-germ cell co-culture in-
cubated for 6 h with a minimum dose of 300 nM (Mitra et al., 2013b).
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ed; some studies found TBT, DBT (dibutyltin), and MBT (monobutyltin)
levels in human tissues in the range of 3–100 nM (Kannan et al., 1999;
Takahashi et al., 1999). Butyltin compounds were already found in
human blood in concentrations ranging between 64 and 155 ng/mL
(Whalen et al., 1999), in particular TBT have been found up to 261 nM.
This variability could be related to human diet, food habits, gender and
physiological stage which should be taken into account; controlled trial
in animal models could overcome this problem.
Recently, very interesting studies, using rodent model, correlated
TBT to cardiovascular disorders impairing the coronary vascular reactiv-
ity response to estradiol and producing endothelial denudation in iso-
lated rat heart (Dos Santos et al., 2012) and demonstrated TBT ability
to reduce vasoconstrictor response in isolated aortic rings of female
rats (Rodrigues et al., 2014).
Among cellular components of vasculature, the endothelium is espe-
cially susceptive to plasma toxicants because it is structurally arranged
in a single layer of cells that ﬁrst come into contact with blood vessel
contents. Further, injuries to endothelial cells are implicated in the path-
ophysiology of several diseases (Yamada et al., 2011) and in particular
in the cardiovascular ones (Mordi and Tzemos, 2014).
Based on the recent demonstration that TBT can inﬂuence vascular
system and on the absence of speciﬁc studies of TBT effects on endothe-
lial cells, we aimed to evaluate the toxicity of TBT onmammalian endo-
thelial cells, using primary cultures of porcine aortic endothelial cells
(pAECs), swine being an excellent animal model in the ﬁeld of cardio-
vascular research (Forni et al., 2005; Vilahur et al., 2011; Zaragoza
et al., 2011; Zannoni et al., 2012; Gessaroli et al., 2012). In addition,
we aimed to investigate the ability of TBT to inﬂuence gene expression
of markers involved in structure and function maintenance and in re-
sponse to injuries of endothelial cells and in estrogen sensitivity. Finally
we evaluate the alteration of endothelial function induced by TBT
through monocyte adhesion assay.
2. Materials and methods
2.1. Chemicals and reagents
Human endothelial SFMmedium, heat inactivated FBS (fetal bovine
serum) and fungizone were purchased from Gibco-Life technologies.
Trypsin-EDTA solution 1×, dimethyl sulfoxide (DMSO) and tributyltin
chloride (TBT) were from Sigma-Aldrich and Dulbecco's phosphate
buffered saline (DPBS) from EuroClone. AlexaFluor 488 Annexin/dead
cell apoptosis kit (Molecular Probes, Eugene, USA Invitrogen) and
CytoTox 96Non-radioactive Cytotoxicity Assay (Promega. Promega Cor-
poration 2800WoodsHollowRoadMadison,WI 53711USA)were used.
NucleoSpin RNAkit (Macherey-Nagel GmbH& Co. KG Postfach 10 13 52
D-52313 Düren Germany) was used for RNA isolation and IScript cDNA
synthesis kit, IQ Supermix and IQ SyBR Green Supermix (Bio-Rad Labo-
ratories Inc., Hercules, CA, USA) were used for cDNA synthesis and RT-
PCR analysis.
2.2. Cell culture
pAECs were isolated and maintained as previously described by
Bernardini et al. (2005) and used from the third to the sixth passage.
Theﬁrst seeding after thawingwas always performed in T-25 tissue cul-
ture ﬂasks (3 × 105 cells/ﬂask) (T25-Falcon, Beckton-Dickinson, Frank-
lin Lakes, NJ, USA) and successive experiments were conducted in 24-
well (qPCR analysis and monocyte adhesion assay) or 96-well assay
plates (cell viability) (Falcon Beckton-Dickinson) with conﬂuent cul-
tures. Cells were cultured in human endothelial SFM medium, added
with FBS (5%) and antimicrobial/antimycotic solution (1× Gibco-Life
technologies code 15240-062) at 38.5 °C. The tributyltin chloride was
diluted in DMSO until a 5mMsolution and therefore in culturemedium
to obtain desired concentrations for cell exposure.2.3. Cell viability
The ability of TBT to induce cytotoxicity was evaluated by the
CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega BioSciences
LLC San Luis Obispo, CA, USA) that quantitatively measures lactate de-
hydrogenase (LDH), a stable cytosolic enzyme that is released upon
cell lysis.
Conﬂuent pAECswere incubated for 24 h in a 96 well plate with TBT
(0, 100, 250, 500, 750, and 1000 nM) and the supernatant was collected
to be analyzed. Themaximum LDH activity was assessed by lysing cells,
collecting the resulting medium and processing it as other samples.
Brieﬂy, supernatant was incubated with a reconstructed substrate mix
for 30min at room temperature, protected from light. Then, a stop solu-
tion was added and the absorbance was recorded at 490 nm. Cytotoxic-
ity of TBT was calculated according to the equation:% Cytotoxicity =
Experimental LDH release (OD 490) / Maximum LDH release (OD 490).
To determine the ability of TBT to induce apoptosis or necrosis
the Annexin V binding assay was employed. This assay detects
phosphatidilserine (PS) externalization on the plasma membrane.
In viable cells PS is located on the cytoplasmic surface of the cellmem-
brane. However during the early stage of apoptosis, PS is translocated
from the inner to the outer leaﬂet of the plasma membrane.
Conﬂuent pAECs cultures were incubated in a 24 well plate with in-
creasing doses of TBT and the Annexin V/PI binding assay (Alexa Fluor®
488, Life Technologies) was used.
Cells were harvested, placed in Eppendorf tubes, centrifuged at
500× g for 10min and resuspended in 100 μL of Annexin binding buffer.
Annexin V-FITC (5 μL) and propidium iodide (1 μL) were added to cell
suspension. After incubation, the cells were analyzed with a ﬂow
cytometer (FACSAria; BD Biosciences) by collecting at least 104 events.
2.4. RNA isolation and quantitative real time PCR (qPCR)
To determine the ability of TBT to inﬂuence endothelial gene expres-
sion, conﬂuent pAECswere incubated for different times (1, 7, and 15 h)
with different doses of TBT (0, 100 or 500 nM).
Total RNA was isolated using the NucleoSpin®RNA Kit (Macherey-
Nagel GmbH & Co. KG, Germany), and 1 μg of total high quality RNA
(A260/A280 ratio above 2.0) was reverse-transcribed to cDNA using the
iScript cDNA Synthesis Kit (Bio-RAD Laboratories Inc., California, USA)
in a ﬁnal volume of 20 μL. Swine primers were designed using Beacon
Designer 2.07 (Premier Biosoft International, Palo Alto, CA, USA) for
each studied gene: estrogen receptor 1 and 2 (ER-1; ER-2); tight junction
proteins: occludin (OCLN) and tight junction protein-1 (ZO-1); adhesion
molecules: vascular cell adhesion molecule-1 (VCAM-1) and intercellu-
lar adhesionmolecule-1 (ICAM-1); cytokine: interleukin-6 (IL-6). More-
over, primers for the following reference genes glyceraldehyde-3-
phosphate dehydrogenase (GAPDH), β-actin and hypoxanthine-guanine
phosphoribosyltransferase (HPRT-) were designed in order to evaluate
the most suitable using BestKeeper Software (Pfafﬂ et al., 2004) for
qPCR normalization. Primer sequences, expected PCR product lengths
and accession numbers in the NCBI database are shown in Table 1. Quan-
titative real-time PCR was performed to evaluate gene expression pro-
ﬁles in iCycler (Bio-RAD) using SYBR green I detection system. The
ampliﬁcation reaction (25 μL) contained 12.5 μL of IQ SYBER Green Bio-
RAD Supermix (Bio-RAD), 1 μL of each forward and reverse primer
(5 μM), 2.5 μL cDNA and 8 μL ofwater. All sampleswere performed in du-
plicate and controls lacking cDNA template were included to determine
the speciﬁcity of target ampliﬁcation. The real-time program included an
initial denaturation for 1min 30s at 95 °C, 40 cycles of 95 °C for 15 s, and
60 °C for 30s, followed by a melting step with ramping from 55 °C to
95 °C at a rate of 0.5 °C/10s. Speciﬁcity of the ampliﬁed PCR products
was conﬁrmed by melting curve analyses and agarose gel electrophore-
sis. The expression level of interest genes was calculated as fold of in-
crease using the 2−ΔΔCT method (Livak and Schmittgen, 2001) in
relation to pAECs cultured under standard conditions (control).
Table 1
Sequences, expected PCR product lengths, and accession numbers in the NCBI database of the swine primers for indicated genes.
Gene Sequence (5′–3′) Length (bp) Acc. no.
Estrogen receptor 1 (ESR-1) For: CGGAGAGGAGGGAGAATGTTG 142 bp NM214220
Rev: GGCTGTTCTTCTTAGTGTGTTTAAT
Estrogen receptor 2 (ESR-2) For: AACCTTAACTCTCCTGTCTCCTAC 250 bp NM001001533
Rev: GCTGGCAATGGATGGCTAAAG
Occludin (OCLN) For: ATCAACAAAGGCAACTCT 157 bp NM001163647.2
Rev: GCAGCAGCCATGTACTCT
Zonula occludens-1 (ZO-1) For: AGTGCCGCCTCCTGAGTTTG 147 bp AJ318101
Rev: CCATCCTCATCTTCATCATCTTCTACAG
Vascular cell adhesion molecule (VCAM-1) For: GAGGATGGAAGATTCTGGAATTTACG 172 bp NM213891
Rev: ATCACTAGAGCAGGTCATGTTCAC
Intercellular adhesion molecule (ICAM-1) For: GCCACTAACAATCACGCATAATG 212 bp NM213816
Rev: TGCTCACTGTAGTCCCTTCTG
Interleukin-6 (IL-6) For: CTGGCAGAAAACAACCTGAACC 94 bp NM214399.1
Rev: TGATTCTCATCAAGCAGGTCTCC
β-actin (Act) For: ATCGTGCGGACATCAAGGA 169 bp AJ312193
Rev: AGGAAGGAGGGCTGGAAGAG
GAPDH For: TGGTGAAGGTCGGAGTGAAC 120 bp AF017079
Rev: TGTAGTGGAGGTCAATGAAGGG
HPRT For: GGACAGGACTGAACGGCTTG 115 bp AF143818
Rev: GTAATCCAGCAGGTCAGCAAAG
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Separation of peripheral blood mononuclear cells (PBMC) was per-
formed by Lympholyte-H (Cedarlane, Burlington, NC, USA) following
the instruction. PBMC were washed twice with PBS, suspended in
DMEM supplemented with 10% FBS and placed on a Petri dish for 1 h
at 38.5 °C in a humidiﬁed 5% CO2 atmosphere to allow cells adhesion.
Then, the culture medium containing non-adherent cells was removed
and medium was replaced. After 48 h of culture, cells were detached
using a scraper and suspended in DMEM supplemented with 10% FBS
(Cutini et al., 2012).
Monocyte adhesion assay was performed according to Lim et al.
(2011). pAECswere treatedwith TBT 0, 100 or 500nM for 1 h. Fresh cul-
turemedium containing 1.5 × 104 PBMCwas added in eachwell and in-
cubated for 2 h at 38.5 °C in a humidiﬁed 5% CO2. Unbound cells were
removed by washing with PBS. PBMC adhering to pAEC layer were
counted in 5 randomly selected ﬁelds for each well.2.6. Statistical analysis
All the data were analyzed with the Shapiro–Wilk test, to assess
whether they are modeled by a normal distribution, and with the
Levene test, to assess whether the variances are comparable.
Normal distribution of data and homoscedasticity were assumed,
with P value N 0.05. Data were analyzed through Student's t-test com-
paring treatments in relation to the control. Statistical analysis was car-
ried out by using R software (http://www.R-project.org)3. Results
3.1. Effect of TBT on cell viability
pAECs exposed to TBT lost gradually their typical morphology of
continuous monolayer and an increasing number of detached cells ap-
peared related to the increase of TBT dose (Fig. 1A). The loss of cells vi-
ability is demonstrated by LDH release: TBT induced signiﬁcant
decrease of cell viability from the dose of 250 nM (Fig. 1B). The ﬂow
cytometric data showed that TBT is capable to induce both apoptosis
and necrosis (Fig. 1C), even if apoptosis was prevalent at lower doses
(data not shown).3.2. Effect of TBT on gene expression
ThemRNAexpression stability of the commonly used reference gene
(GAPDH, HPRT, β-actin) revealed that β-actin expression was reduced
after TBT exposure (data not shown). Therefore, GAPDH and HPRT geo-
metric mean value of Ct was used for normalization of qPCR data.
Both tight junction molecules OCLN and ZO-1 were lower in pAECs
treated with respect to pAECs under standard culture conditions starting
from 7 h of exposure at 500 nM TBT (Fig. 2B; D); moreover ZO-1 expres-
sion showed signiﬁcant decrease also at low dose (Fig. 2C). The adhesion
molecules, VCAM-1 and ICAM-1 showed a signiﬁcant transient increase
at 1 h at both doses, followed by a decrease (Fig. 3).
IL-6mRNAwas transiently reduced at early times for both TBT doses.
After 15 h of exposure at TBT 500 nM the IL-6 expression was signiﬁ-
cantly increased (Fig. 4).
The transcript of both estrogen receptorswas signiﬁcantly decreased
at both doses after 1 and 7 h, then, at 15 h, both receptors increased even
if only ER-1 was signiﬁcantly increased with TBT 500 nM (Fig. 5).
3.3. Effect of TBT on monocyte adhesion
Increasedmonocyte adhesionwas observed after TBT treatment and
monocyte adhesion assay (Fig. 6). As shown in Fig. 6C the TBT treatment
signiﬁcantly increased monocyte adhesion.
4. Discussion
Among different cellular types, the endothelium, uniquely positioned
at the interface between the vessel wall and ﬂowing blood, can be a rele-
vant target for TBT toxic action. The endothelial layer, in fact, regulates
multiple functions such asmaintenance of normal vascular tone,modula-
tion of coagulation, and immune responses (Maney et al., 2011) andmay
contribute to vascular disorders (Aki et al., 2008). Therefore, being endo-
thelial cells directly exposed to the TBT accumulated in the bloodstream
as a result of biomagniﬁcation, it is important to investigate in which ex-
tent they are affected in relation to its principal features.
Our study demonstrated that TBT signiﬁcantly reduced the viability
of pAECs, displaying a consistent dose–response relation. Accordingly,
the cell deathmechanism, namely apoptosis or necrosis, is known to de-
pend on the TBT dose and exposure time (Pagliarani et al., 2013). The
cytotoxic effect of TBT on pAECs was observed at 250 nM dose, compa-
rable to that one exhibited in neuroblastoma cell (Ferreira et al., 2013).
Fig. 1. A) Representative images of pAECsmorphology under standard culture conditions or in the presence of increasing TBT doses; cultures exposed to TBT demonstrated a higher num-
ber of detached cells. Effect of TBT on cell viability. B) Cytotoxicity assessed by LDH release assay on pAECs exposed to increasing TBT concentrations. Data represent mean ± SE of four
independent experiments **P b 0.01. C) Annexin V/PI binding assay, representative cytograms showing control (left) and pAECs exposed to TBT 1000 nM (right). TBT treatment induced
both apoptotic and necrotic cells.
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ture:mouse neurons exhibit signs of toxicity and death from concentra-
tions of 30 nM (Yamada et al., 2010) while rat or trout hepatocytes
begin to die from 2 μM (Reader et al., 1999; Jurkiewicz et al., 2004).
The lowest dose utilized had no signiﬁcant effects on cell viability,
however, it had a relevant effect on gene expression, this result is tobe considered taking into account that in human blood TBT was found
until 155 ng/mL (Whalen et al., 1999).
Expression of genes related to tight junctions (OCLN and ZO-1) was
reduced by TBT exposure conﬁrming the morphological alterations ob-
served and consistently with an increased number of round and de-
tached cells. Therefore, from a functional point of view, TBT alters the
Fig. 2. Relative gene expression of tight junction: OCLN (A, B) and ZO-1 (C, D) in pAECs treated with TBT (100 and 500 nM) at different periods (1, 7 and 15 h). Relative expression was
calculated as fold of change in respect to the control cells (2−ΔΔCt method). Error bar represents the range of relative expression. **P b 0.01 and *P b 0.05 when compared to control.
Occludin (OCLN); zonula occludens-1 (ZO-1).
83G. Botelho et al. / Comparative Biochemistry and Physiology, Part C 176–177 (2015) 79–86typical architecture of endothelial cell–cell junctions, consistent with
previous reports in various mammalian cell types such as epithelial
cell in vitro (Tsukazaki et al., 2004), prostate cells in vivo (Barthelemy
et al., 2007), and isolated heart cells ex vivo (Dos Santos et al., 2012).
Adhesion molecules, responsible for mediating the aggregation of
cells to endothelium, are consideredmarkers of endothelial dysfunction
and are used to predict potential vascular risk (Wiseman et al., 2014).
VCAM-1 is constitutively expressed on endothelial cells and mediates
tethering and rolling of lymphocytes and monocytes (Tu el al., 2013).
ICAM-1 is constitutively expressed on the cell surface of endothelialFig. 3. Effect of TBT exposure on expression levels of genes related to adhesion molecules: VCAM
riods (1, 7 and15h). Relative expressionwas calculated as fold of change in respect to the contro
*P b 0.05. Intercellular adhesion molecule-1 (ICAM-1); vascular cell adhesion molecule-1 (VCAcells and leukocytes and functionally activates leukocyte–endothelial
adhesion and migration. The effect of TBT on ICAM-1 and VCAM-1
gene expression, in our model, followed the same trend with an initial
increase and a subsequent decrease, in accordance with the modiﬁca-
tion that occurs at the beginning of an endothelium dysfunction
(Burger and Touys, 2012). Consistently, as adhesion molecules mediate
the adherence of circulating leukocytes to the vascular endothelium,
TBT treatment strongly increased monocytes adhesion to pAECs.
The response of endothelial cells to a toxic injury often involves sever-
al changes in inﬂammatory mediators. IL-6 is a pleiotropic cytokine, it-1 (A, B) and ICAM-1 (C, D) in pAECs treated with TBT (100 and 500 nM) at different pe-
l cells (2−ΔΔCtmethod). Error bar represents the range of relative expression. **P b 0.01 and
M-1).
Fig. 4. Effect of TBT exposure on expression levels of IL-6 gene in pAECs treatedwith TBT 100 nM(A) and 500 nM(B) at different periods (1, 7 and 15h). Relative expressionwas calculated
as fold of change in respect to the control cells (2−ΔΔCt method). Error bar represents the range of relative expression. **P b 0.01 and *P b 0.05. Interleukin 6 (IL-6).
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proliferation and participate to the regulation of inﬂammatory responses
driving adhesion molecules synthesis in endothelial cells (Fogal et al.,
2011). IL-6 is also a potent proangiogenic cytokine regulating vascular en-
dothelial growth factor (VEGF) secretion (Nilsson et al., 2005; Pober et al.,
2009); different cell types produce IL-6 among these, endothelial cells are
one of the major sources of plasma IL-6 (Tanaka et al., 2014).
In our model, TBT was able to reduce IL-6 mRNA expression at early
times for both doses. However TBT 500 nM strongly increased the IL-6
mRNA expression after 15 h of treatment, in accordance with data ob-
served by Mitra et al. (2013a) in neural dissociated cortical cells and
likely in an effort to induce cell survival through VEGF.
The interaction of organotin with nuclear receptors is well known,
they augment adipogenesis via the interaction with PPARγ/RXRα (Grün
and Blumberg, 2006) and inhibit estrogen with a systemic action and/or
through repression of ER synthesis (McAllister and Kime, 2003; Delfosse
et al., Epub ahead of print). The expression of the two estrogen genes re-
ceptors was altered by TBT: the expression decreased until 7 h at both
doses, while a strong increase was observed after 15 h only with the
highest dose. Similarly, Zhang et al. (2013) show that TBT affected the
ERs gene expression in male rockﬁsh (Sebastiscus marmoratus) leading
to an increase or a decrease depending on the applied concentrations.Fig. 5. Effect of TBT exposure on expression levels of ESR-1 and ESR-2 genes in pAECs treated
calculated as fold of change in respect to the control cells (2−ΔΔCt method). Error bar represents
(ESR-2).Further investigations will be necessary to clarify the functional
impact of this estrogen receptor alteration. Themultiple effects of es-
trogens mediated by ERs include endothelial proliferation, endothe-
lial apoptosis inhibition, and modulation of adhesion molecules with
an overall protective effect against cardiovascular diseases
(Mendelsohn and Karas, 2005; Mosca et al., 2011). In fact it is well
known that the incidence of cardiovascular disease differs signiﬁ-
cantly between man and woman being lower in man and in post-
menopausal women.
Overall the exposure of endothelial cells to TBT induced a wide
range of effects all consistent with endothelial dysfunction that repre-
sents theﬁrst stage ofmanyvascular diseases. In ourmodel TBT induced
shifts from an anti- to a pro-adhesive endothelial phenotype that is the
ﬁrst step of inﬂammatory process and an important risk factor for car-
diovascular diseases (Aird, 2008). Moreover we demonstrate the
alteration of cell–cell junctions that is known to be responsible
in vivo for alteration of permeability exiting in edema and vascular fra-
gility (Dejana et al., 2009).
The role of ER in triggering the TBT effects on endothelial cells and, in
turn, on cardiovascular diseases, must be deeply investigated due to the
clear protective effect that estrogens exert on cardiovascular systemand
the power of TBT to alter steroidogenesis.with TBT (100 and 500 nM) at different periods (1, 7 and 15 h). Relative expression was
the range of relative expression. *P b 0.05. Estrogen receptor 1 (ESR-1); estrogen receptor
Fig. 6. Effect of TBT onmonocyte adhesion. A) pAECs in standard culture condition (control); B, C) pAECs treatedwith TBT 100nMor 500 respectively (10×). The arrows indicated adhered
monocytes. D) Bars represent the mean monocyte adhesion rate represented as the percentage compared with control group. *P b 0.01.
85G. Botelho et al. / Comparative Biochemistry and Physiology, Part C 176–177 (2015) 79–86Therefore, further in vivo investigation using pig model will be nec-
essary to understand the pathological implication of TBT contamination
in the development of cardiovascular alterations.Acknowledgments
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